United Therapeutics | UTHR - Operating Profit

Stock Price
473.66
Daily Change
-2.47 -0.52%
Monthly
-0.44%
Yearly
27.82%
Q1 Forecast
470.46

United Therapeutics reported $389.3M in Operating Profit for its fiscal quarter ending in September of 2025.





Operating Profit Change Date
Amarin USD -1.7M 8.47M Sep/2025
Ardelyx USD 4.67M 19.07M Sep/2025
Baxter International USD -214.2M 415.4M Dec/2025
Bayer EUR -543M 556M Sep/2025
BioCryst Pharmaceuticals USD -2.54M 10.23M Dec/2024
Biogen USD 659.6M 192.2M Sep/2025
BioMarin Pharmaceutical USD -31.69M 308.58M Sep/2025
Esperion Therapeutics USD -16.03M 18.6M Sep/2024
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Halozyme Therapeutics USD 217.92M 15.48M Sep/2025
Insmed USD -261.35M 7.48M Sep/2025
Ionis Pharmaceuticals USD -160.18M 300.02M Sep/2025
J&J USD 5.59B 1.81B Dec/2025
Lexicon Pharmaceuticals USD -55.35M 10.02M Jun/2024
Moderna USD -857M 597M Dec/2025
Omeros USD -35.41M 23.75M Sep/2024
Pfizer USD 4.65B 3.99B Dec/2025
PTC Therapeutics USD 3.49M 38.35M Sep/2025
Regeneron Pharmaceuticals USD 898.6M 211.3M Dec/2025
Sangamo BioSciences USD -33.51M 12.77M Jun/2024
Sarepta Therapeutics USD -62.88M 178.46M Sep/2025
Teva Pharmaceutical Industries USD 487M 581M Dec/2025
United Therapeutics USD 389.3M 112.4M Sep/2025
Vertex Pharmaceuticals USD 1.26B 24.5M Dec/2025